These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18261866)

  • 1. Characteristics of polymers enabling nano-comminution of water-insoluble drugs.
    Lee J; Choi JY; Park CH
    Int J Pharm; 2008 May; 355(1-2):328-36. PubMed ID: 18261866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of polymer molecular weight on nanocomminution of poorly soluble drug.
    Choi JY; Park CH; Lee J
    Drug Deliv; 2008 Jun; 15(5):347-53. PubMed ID: 18763166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymer-surfactant nanoparticles for sustained release of water-soluble drugs.
    Chavanpatil MD; Khdair A; Patil Y; Handa H; Mao G; Panyam J
    J Pharm Sci; 2007 Dec; 96(12):3379-89. PubMed ID: 17721942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the combination of cellulosic polymers and anionic surfactants a good strategy for ensuring physical stability of BCS Class II drug nanosuspensions?
    Bilgili E; Li M; Afolabi A
    Pharm Dev Technol; 2016; 21(4):499-510. PubMed ID: 25774989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
    Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L
    Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APPLICATION OF VARIOUS POLYMERS AND POLYMERS BASED TECHNIQUES USED TO IMPROVE SOLUBILITY OF POORLY WATER SOLUBLE DRUGS: A REVIEW.
    Muhammad Sarfraz R; Bashir S; Mahmood A; Ahsan H; Riaz H; Raza H; Rashid Z; Atif Raza S; Asad Abrar M; Abbas K; Yasmeen T
    Acta Pol Pharm; 2017 Mar; 74(2):347-356. PubMed ID: 29624239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
    Cho E; Cho W; Cha KH; Park J; Kim MS; Kim JS; Park HJ; Hwang SJ
    Int J Pharm; 2010 Aug; 396(1-2):91-8. PubMed ID: 20558265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic screening of different surface modifiers for the production of physically stable nanosuspensions.
    Lestari ML; Müller RH; Möschwitzer JP
    J Pharm Sci; 2015 Mar; 104(3):1128-40. PubMed ID: 25630623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation strategy and use of excipients in pulmonary drug delivery.
    Pilcer G; Amighi K
    Int J Pharm; 2010 Jun; 392(1-2):1-19. PubMed ID: 20223286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process.
    Abuzar SM; Hyun SM; Kim JH; Park HJ; Kim MS; Park JS; Hwang SJ
    Int J Pharm; 2018 Mar; 538(1-2):1-13. PubMed ID: 29278733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanosizing of a drug/carrageenan complex to increase solubility and dissolution rate.
    Dai WG; Dong LC; Song YQ
    Int J Pharm; 2007 Sep; 342(1-2):201-7. PubMed ID: 17560055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
    Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
    Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased dissolution and physical stability of micronized nifedipine particles encapsulated with a biocompatible polymer and surfactants in a wet ball milling process.
    Li N; DeGennaro MD; Liebenberg W; Tiedt LR; Zahr AS; Pishko MV; de Villiers MM
    Pharmazie; 2006 Jul; 61(7):595-603. PubMed ID: 16889066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal wet-milling technique to prepare oral nanosuspension focused on discovery and preclinical animal studies - Development of particle design method.
    Niwa T; Miura S; Danjo K
    Int J Pharm; 2011 Feb; 405(1-2):218-27. PubMed ID: 21167922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards sustainability: new approaches to nano-drug preparation.
    Cheow WS; Xu R; Hadinoto K
    Curr Pharm Des; 2013; 19(35):6229-45. PubMed ID: 23469999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoglyceride-based self-assembling copolymers as carriers for poorly water-soluble drugs.
    Rouxhet L; Dinguizli M; Latere Dwan'isa JP; Ould-Ouali L; Twaddle P; Nathan A; Brewster ME; Rosenblatt J; Ariën A; Préat V
    Int J Pharm; 2009 Dec; 382(1-2):244-53. PubMed ID: 19666096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
    Widanapathirana L; Tale S; Reineke TM
    Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.